Cavaillé-Coll MW and Elashoff MR |
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation. |
1998 |
Transplantation |
pmid:9448161
|
Gjertson DW et al. |
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. |
1995 |
Transplantation |
pmid:8545861
|
Ellis D et al. |
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10532541
|
First MR and Fitzsimmons WE |
New drugs to improve transplant outcomes. |
2004 |
Transplantation |
pmid:15201693
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Hashimoto T et al. |
Treatment with FK506 prevents rejection of rat colon allografts. |
1994 |
Transplantation |
pmid:7516586
|
Jain AB et al. |
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. |
2004 |
Transplantation |
pmid:15077034
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Weir MR et al. |
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. |
2017 |
Transplantation |
pmid:26950714
|
Ravindran VK et al. |
Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. |
2009 |
Transplantation |
pmid:19543067
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Murase N et al. |
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. |
1990 |
Transplantation |
pmid:1696405
|
Propper DJ et al. |
FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions. |
1990 |
Transplantation |
pmid:1696409
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation. |
2017 |
Transplantation |
pmid:27482958
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis. |
2006 |
Transplantation |
pmid:16570006
|
Reddy KS et al. |
Simultaneous kidney-pancreas transplantation without antilymphocyte induction. |
2000 |
Transplantation |
pmid:10653379
|
Jevnikar A et al. |
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure. |
2008 |
Transplantation |
pmid:18852662
|
Bronster DJ et al. |
Demyelinating sensorimotor polyneuropathy after administration of FK506. |
1995 |
Transplantation |
pmid:7535959
|
Ninova D et al. |
Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. |
2004 |
Transplantation |
pmid:15316360
|
Naesens M and Sarwal MM |
Monitoring calcineurin inhibitor therapy: localizing the moving target. |
2010 |
Transplantation |
pmid:20458272
|
Herlenius G et al. |
Chronic kidney disease--a common and serious complication after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622286
|
Ceulemans LJ et al. |
Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation. |
2015 |
Transplantation |
pmid:25695790
|
Watson MJ et al. |
Renal function impacts outcomes after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622288
|
McLaren A |
Tacrolimus pharmacogenetics: bringing the laboratory into the clinic. |
2003 |
Transplantation |
pmid:14705621
|
Jun KR et al. |
Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. |
2009 |
Transplantation |
pmid:19384171
|
Roberts CA et al. |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. |
2002 |
Transplantation |
pmid:12364862
|
Inamura N et al. |
Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. |
1988 |
Transplantation |
pmid:2447690
|
Radkowski M et al. |
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9753352
|
Egashira K et al. |
Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. |
2003 |
Transplantation |
pmid:12698101
|
Hu H et al. |
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. |
2003 |
Transplantation |
pmid:12698107
|
Hebert MF et al. |
Interpreting tacrolimus concentrations during pregnancy and postpartum. |
2013 |
Transplantation |
pmid:23274970
|
Fujishiro J et al. |
Immunologic benefits of longer graft in rat allogenic small bowel transplantation. |
2005 |
Transplantation |
pmid:15665767
|
Farley DE et al. |
The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. |
1991 |
Transplantation |
pmid:1713360
|
Thai NL et al. |
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. |
2006 |
Transplantation |
pmid:17198253
|
Holländer GA et al. |
Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. |
1994 |
Transplantation |
pmid:7526495
|
Gruessner RW et al. |
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. |
1996 |
Transplantation |
pmid:8600635
|
Aisa Y et al. |
Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation. |
2005 |
Transplantation |
pmid:16278584
|
Tanaka J et al. |
The immunosuppressive agent FK506 enhances the cytolytic activity of inhibitory natural killer cell receptor (CD94/NKG2A)-expressing CD8 T cells. |
2005 |
Transplantation |
pmid:16378079
|
Dharancy S et al. |
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. |
2007 |
Transplantation |
pmid:17460561
|
Vadivel N et al. |
Tacrolimus dose in black renal transplant recipients. |
2007 |
Transplantation |
pmid:17460575
|
Neuhaus PJ |
Optimised first-line FK506-based protocols in liver transplantation: experience from the University Hospital Rudolf Virchow, Berlin. |
1994 |
Transplant. Proc. |
pmid:7527961
|
Jordan ML et al. |
FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679827
|
Fougeray S et al. |
Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers. |
2011 |
Transplant. Proc. |
pmid:22099811
|
Jusko WJ and D'Ambrosio R |
Monitoring FK 506 concentrations in plasma and whole blood. |
1991 |
Transplant. Proc. |
pmid:1721260
|
Tang J et al. |
Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27788813
|
Millis JM et al. |
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623213
|
Neylan JF |
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636551
|
Tanabe K et al. |
ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119903
|
Elmer DS et al. |
Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. |
1998 |
Transplant. Proc. |
pmid:9532159
|
Berman M et al. |
Lipid metabolism and immunosuppressive therapy in heart transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12644091
|
Marcén R et al. |
Evolution of rejection rates and kidney graft survival: a historical analysis. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715918
|
Lauzurica R et al. |
Monotherapy with tacrolimus and corticosteroid withdrawal. |
2002 |
Transplant. Proc. |
pmid:11959217
|
Monden M et al. |
A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. |
1990 |
Transplant. Proc. |
pmid:1689904
|
Klintmalm GB |
Clinical use of FK 506 in liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623484
|
Mano A et al. |
Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report. |
2009 |
Transplant. Proc. |
pmid:19917396
|
Lampreabe I et al. |
Toward personalized medicine in renal transplantation. |
2010 |
Transplant. Proc. |
pmid:20970553
|
Sato K et al. |
Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249521
|
Spada M et al. |
Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518141
|
Yasunami Y et al. |
Induction of donor-specific unresponsiveness in rat islet allografts by FK 506. |
1992 |
Transplant. Proc. |
pmid:1376510
|
Martinez OM et al. |
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533372
|
Motta I et al. |
FK 506 favors the generation of memory T cells in vitro. |
1991 |
Transplant. Proc. |
pmid:1721324
|
Wojewodzka J et al. |
Inhibition of formation of synapses between dendritic cells and lymphocytes in skin lymph in an allogeneic reaction by cyclosporine and tacrolimus. |
2003 |
Transplant. Proc. |
pmid:14529947
|
Isai H et al. |
FK 506 and orthotopic liver transplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1699329
|
Suga A et al. |
Diabetes mellitus after renal transplantation under tacrolimus-based immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12591391
|
Koefoed-Nielsen PB et al. |
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. |
2005 |
Transplant. Proc. |
pmid:15919449
|
Aguirrezabalaga J et al. |
Lipid profiles after liver transplantation in patients receiving tacrolimus or cyclosporin. |
2002 |
Transplant. Proc. |
pmid:12176480
|
Shapiro R et al. |
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533432
|
Gerauer K et al. |
Long-term cardiac allograft survival in mice treated with malononitrilamide 715. |
1998 |
Transplant. Proc. |
pmid:9865349
|
Whiteside TL et al. |
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721356
|
Hossain MA et al. |
Immunosuppression in auxiliary partial liver transplantation with FK506 in rats. |
1997 |
Transplant. Proc. |
pmid:9414861
|
Parada MT et al. |
Everolimus in lung transplantation in Chile. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172343
|
Weimer R et al. |
Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study. |
2002 |
Transplant. Proc. |
pmid:12270445
|
Oltean M et al. |
FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis. |
2005 |
Transplant. Proc. |
pmid:15919508
|
Ciftci HS et al. |
Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. |
2013 |
Transplant. Proc. |
pmid:23622581
|
Jordan ML et al. |
Five-year experience with tacrolimus rescue for renal allograft rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123009
|
Fahlke J et al. |
Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study. |
2002 |
Transplant. Proc. |
pmid:12072328
|
Yamada T et al. |
Synergistic effect of FK 506 and trifluoperazine on the immunosuppression in rat small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907927
|
Uchida K et al. |
Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan. |
2002 |
Transplant. Proc. |
pmid:12176503
|
Calia R et al. |
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620041
|
Kim YI et al. |
FK 506 prevents critical warm ischemia damage to the pig liver and improves hepatic microcirculation. |
1994 |
Transplant. Proc. |
pmid:7520636
|
Humar A et al. |
Surgical complications requiring early relaparotomy after pancreas transplantation: comparison of the cyclosporine and FK 506 eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083256
|
Sanghvi A et al. |
Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein. |
1989 |
Transplant. Proc. |
pmid:2468204
|
Winkler M et al. |
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721389
|
Lee PC et al. |
Cyclosporine or tacrolimus: which is the better partner for myfortic or cellcept? |
2012 |
Transplant. Proc. |
pmid:22310598
|
Berloco P et al. |
Tacrolimus as cornerstone immunosuppressant in kidney transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267161
|
Cooper MH et al. |
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721419
|
Yagura K et al. |
Pharmacokinetic characteristics of two types of liposomal FK 506. |
1996 |
Transplant. Proc. |
pmid:8658708
|
Shi Y et al. |
Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China. |
|
Transplant. Proc. |
pmid:28104150
|
Ozkurt S et al. |
Late effects of renal transplantation on endothelial functions and cardiac morphology. |
2011 |
Transplant. Proc. |
pmid:21911132
|
Alkhunaizi AM et al. |
Breast fibroadenomas in renal transplant recipients. |
2004 Jul-Aug |
Transplant. Proc. |
pmid:15350492
|
Lauro A et al. |
Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning? |
2005 |
Transplant. Proc. |
pmid:15964382
|
Alberti D et al. |
Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723310
|
Flechner SM |
Minimizing calcineurin inhibitor drugs in renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12742481
|
El-Sabrout R et al. |
Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus-tacrolimus combination. |
2002 |
Transplant. Proc. |
pmid:12176638
|
Doesch AO et al. |
Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. |
2010 |
Transplant. Proc. |
pmid:21168673
|
Alvarez-ElÃas AC et al. |
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. |
2016 |
Transplant. Proc. |
pmid:27110018
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients. |
1999 |
Transplant. Proc. |
pmid:10500604
|
Wu J et al. |
Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation. |
1991 |
Transplant. Proc. |
pmid:1703683
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|